Ayala Pharmaceuticals Inc (ADXS)

[bill_y]

if adxs really has the ability to enhance other systems/treatments it would pay amgen, bmy, astra, merck to keep adxs as some utility from which they license adxs technology..or am i missing something.and i think we need to see a reduction in short interest before any s/p evaluation..maybe its already in the cards and needs to play out.?